Jessica Hagen
Adam Elsesser, president, chairman and CEO of Penumbra, describes the medical device company's move into virtual reality and how its REAL system helps therapists measure a patient's progress.
The acquisition will allow Color Health to provide behavioral and mental health treatment at scale.
HSS announced it raised $21 million in Series A funds to launch the new company.
The health insurer's members will receive free home delivery for common medications through Amazon Pharmacy.
Consumers can use the tests to detect Lyme disease, vitamin D levels, thyroid function and sexually transmitted infections.
Noala, Elion and Upheal also announced funding rounds.
The company will speed up its clinical trial recruitment measures, raise awareness of post-approval treatments and support cancer research.
The acquisition will expand Unified's portfolio of women-focused companies to include menopause-relief offerings in all 50 states.
When determining approval for Breakthrough Device designation, the FDA will consider whether the device addresses present health inequities.
The neurostimulation device, which is currently for investigational use only, aims to treat cognitive and functional decline in Alzheimer's patients.